Collyer Law is advising a Singapore-based venture capital fund on its minority investment in an agricultural technology company with operations in Singapore and the USA. The company develops robotics and machine-learning solutions aimed at improving crop production and sustainability. The transaction involves dual-structure considerations to ensure contractual parity for the investor between the Singapore and USA entities.

Collyer Law advised a HNW angel investor on the restructuring and funding of a Singapore-based educational and enrichment business specialising in children’s holiday and summer camp programmes. The transaction involved consolidating operations under a new holding structure, acquiring and licensing key intellectual property, and providing growth capital to revitalise and expand the business’s market presence.

Collyer Law advised the largest cricket fantasy league platform on the acquisition of all shares in a Singapore-based NFT marketplace platform (specialising in officially licensed cricket digital collectibles) with global operations, particularly in India, from all its existing shareholders comprising leading venture capital funds, startup founders, angel investors and a national cricket board.

Collyer Law advised a Singapore-based health and longevity clinic focused on reversing biological aging, on its SAFE investment round from an international venture capital fund. The funding will support clinical research, product development and market expansion.

Collyer Law LLC advised a venture capital fund on its investment in the Series A fundraising round of a synthetic biotechnology start-up that develops livestock disease prevention biotechnology. The start-up offers recombinant custom peptides cultivated using synbio microorganisms as an antibiotic replacement for disease prevention and growth promotion in livestock, providing breeders and farmers with humane, sustainable, highly productive agriculture without the use of antib